FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169748531> ?p ?o ?g. }

• W3169748531 abstract "Objectives: Targeting tumor necrosis factor (TNF) with biologic agents, such as infliximab and adalimumab, is a widely used and effective therapeutic strategy in inflammatory bowel disease (IBD). Unfortunately, a significant number of patients fail to respond or lose response over time to these agents. Previous studies have defined multiple complex roles for canonical NF-κB signaling in the pathogenesis of IBD. However, preliminary evidence suggests that the lesser defined noncanonical NF-κB signaling pathway also contributes to disease pathogenesis and response to anti-TNF agents. The objective of this study was to evaluate this hypothesis in Crohn’s disease (CD) and ulcerative colitis (UC) patients. Design: A total of 27 subjects with IBD (19 with CD and 8 with UC) and 15 control subjects were tested. Clinical criteria, patient history, and endoscopic disease activity were factors used to categorize patients and define therapeutic response. Biopsy specimens were collected during colonoscopy and expression was determined for 88 target genes known to be associated with noncanonical NF-κB signaling and IBD. Results: Noncanonical NF-κB signaling was significantly upregulated in IBD patients and was associated with increased gastrointestinal inflammation, epithelial cell death, lymphocyte migration, and Nod-like receptor signaling. Furthermore, noncanonical NF-κB signaling was further upregulated in patients unresponsive to anti-TNF agents and was suppressed in responsive patients. MAP3K14, NFKB2, CCL19, CXCL12 , and CXCL13 were significantly dysregulated, as were genes that encode pathway regulators, such as CYLD, NLRP12, and BIRC2/3 . Conclusion: Our study identifies a previously uncharacterized role for the understudied noncanonical NF-κB signaling pathway in the pathogenesis of IBD and anti-TNF therapy responsiveness. The genes and pathways identified may ultimately prove useful in IBD management and could potentially be used as biomarkers of drug response." @default.
• W3169748531 created "2021-06-22" @default.
• W3169748531 creator A5008179003 @default.
• W3169748531 creator A5015509350 @default.
• W3169748531 creator A5043665456 @default.
• W3169748531 creator A5056073370 @default.
• W3169748531 creator A5063406943 @default.
• W3169748531 creator A5067984432 @default.
• W3169748531 creator A5069877634 @default.
• W3169748531 creator A5077400862 @default.
• W3169748531 creator A5088349342 @default.
• W3169748531 creator A5089616843 @default.
• W3169748531 date "2021-06-10" @default.
• W3169748531 modified "2023-10-13" @default.
• W3169748531 title "Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents" @default.
• W3169748531 cites W1515981258 @default.
• W3169748531 cites W1944754896 @default.
• W3169748531 cites W1971240021 @default.
• W3169748531 cites W2009754157 @default.
• W3169748531 cites W2032661113 @default.
• W3169748531 cites W2052545263 @default.
• W3169748531 cites W2090015658 @default.
• W3169748531 cites W2094159990 @default.
• W3169748531 cites W2094611674 @default.
• W3169748531 cites W2094778049 @default.
• W3169748531 cites W2102013054 @default.
• W3169748531 cites W2114266978 @default.
• W3169748531 cites W2508273371 @default.
• W3169748531 cites W2545034339 @default.
• W3169748531 cites W2552690718 @default.
• W3169748531 cites W2556315980 @default.
• W3169748531 cites W2766046358 @default.
• W3169748531 cites W2781214098 @default.
• W3169748531 cites W2793831655 @default.
• W3169748531 cites W4233817719 @default.
• W3169748531 doi "https://doi.org/10.3389/fphar.2021.655887" @default.
• W3169748531 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8223059" @default.
• W3169748531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34177575" @default.
• W3169748531 hasPublicationYear "2021" @default.
• W3169748531 type Work @default.
• W3169748531 sameAs 3169748531 @default.
• W3169748531 citedByCount "13" @default.
• W3169748531 countsByYear W31697485312022 @default.
• W3169748531 countsByYear W31697485312023 @default.
• W3169748531 crossrefType "journal-article" @default.
• W3169748531 hasAuthorship W3169748531A5008179003 @default.
• W3169748531 hasAuthorship W3169748531A5015509350 @default.
• W3169748531 hasAuthorship W3169748531A5043665456 @default.
• W3169748531 hasAuthorship W3169748531A5056073370 @default.
• W3169748531 hasAuthorship W3169748531A5063406943 @default.
• W3169748531 hasAuthorship W3169748531A5067984432 @default.
• W3169748531 hasAuthorship W3169748531A5069877634 @default.
• W3169748531 hasAuthorship W3169748531A5077400862 @default.
• W3169748531 hasAuthorship W3169748531A5088349342 @default.
• W3169748531 hasAuthorship W3169748531A5089616843 @default.
• W3169748531 hasBestOaLocation W31697485311 @default.
• W3169748531 hasConcept C104317684 @default.
• W3169748531 hasConcept C126322002 @default.
• W3169748531 hasConcept C127561419 @default.
• W3169748531 hasConcept C17991360 @default.
• W3169748531 hasConcept C203014093 @default.
• W3169748531 hasConcept C2776914184 @default.
• W3169748531 hasConcept C2777138892 @default.
• W3169748531 hasConcept C2777730290 @default.
• W3169748531 hasConcept C2778260677 @default.
• W3169748531 hasConcept C2778690821 @default.
• W3169748531 hasConcept C2779134260 @default.
• W3169748531 hasConcept C2780132546 @default.
• W3169748531 hasConcept C2780942790 @default.
• W3169748531 hasConcept C502942594 @default.
• W3169748531 hasConcept C55493867 @default.
• W3169748531 hasConcept C62478195 @default.
• W3169748531 hasConcept C71924100 @default.
• W3169748531 hasConcept C86803240 @default.
• W3169748531 hasConcept C95444343 @default.
• W3169748531 hasConceptScore W3169748531C104317684 @default.
• W3169748531 hasConceptScore W3169748531C126322002 @default.
• W3169748531 hasConceptScore W3169748531C127561419 @default.
• W3169748531 hasConceptScore W3169748531C17991360 @default.
• W3169748531 hasConceptScore W3169748531C203014093 @default.
• W3169748531 hasConceptScore W3169748531C2776914184 @default.
• W3169748531 hasConceptScore W3169748531C2777138892 @default.
• W3169748531 hasConceptScore W3169748531C2777730290 @default.
• W3169748531 hasConceptScore W3169748531C2778260677 @default.
• W3169748531 hasConceptScore W3169748531C2778690821 @default.
• W3169748531 hasConceptScore W3169748531C2779134260 @default.
• W3169748531 hasConceptScore W3169748531C2780132546 @default.
• W3169748531 hasConceptScore W3169748531C2780942790 @default.
• W3169748531 hasConceptScore W3169748531C502942594 @default.
• W3169748531 hasConceptScore W3169748531C55493867 @default.
• W3169748531 hasConceptScore W3169748531C62478195 @default.
• W3169748531 hasConceptScore W3169748531C71924100 @default.
• W3169748531 hasConceptScore W3169748531C86803240 @default.
• W3169748531 hasConceptScore W3169748531C95444343 @default.
• W3169748531 hasLocation W31697485311 @default.
• W3169748531 hasLocation W31697485312 @default.
• W3169748531 hasLocation W31697485313 @default.
• W3169748531 hasOpenAccess W3169748531 @default.
• W3169748531 hasPrimaryLocation W31697485311 @default.
• W3169748531 hasRelatedWork W1588288904 @default.

• next